Article
04 August 2009
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
FDA Authorizes New COVID Vaccines with Restrictions on Eligibility
The Rx for High-Performance Leadership: Cutting Through the Chaos
Pfizer to Lay Off 100 Employees from Former Seagen HQ Amid Cost Cuttings
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
Eli Lilly’s Orforglipron Successfully Completes Third Phase 3 Trial Resulting in Global Regulatory Submissions
Bridging the Gap Between Innovation and Access: Q&A with Matt Riordan